WallStreetZenWallStreetZen

NASDAQ: XLO
Xilio Therapeutics Inc Stock Ownership - Who owns Xilio Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Xilio Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kevin M. BrennanSVP FINANCE AND ACCOUNTING2026-01-021,826$0.64
$1.17kSell
Christopher James FrankenfieldChief Financial Officer2026-01-027,030$0.64
$4.52kSell
James Samuel ShannonDirector2025-06-1725,000$0.69
$17.23kBuy
Rene RussoPRESIDENT AND CEO2025-06-1636,289$0.68
$24.68kBuy
James Samuel ShannonDirector2025-06-1645,000$0.69
$30.87kBuy

1 of 1

XLO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when XLO insiders and whales buy or sell their stock.

XLO Shareholders

What type of owners hold Xilio Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Gilead Sciences Inc242.81%9,105,451$69.75MInsider
Gilead Sciences Inc242.81%9,105,451$69.75MInstitution
Bain Capital Life Sciences Investors LLC196.60%7,372,686$56.47MInstitution
Yekaterina Chudnovsky186.67%7,000,000$53.62MInsider
Frazier Life Sciences Management LP157.73%5,915,091$45.31MInstitution
Point72 Asset Management LP106.67%4,000,000$30.64MInstitution
Sv7 Impact Medicine Fund LP86.06%3,227,264$24.72MInsider
Bain Capital Life Sciences Investors LLC74.81%2,805,413$21.49MInsider
Atlas Venture Fund XI LP73.44%2,754,109$21.10MInsider
James E. Flynn61.01%2,287,944$17.53MInsider

1 of 3

XLO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
XLO53.27%46.73%Net BuyingNet Selling
BRNS19.34%53.37%
IGC5.20%21.83%
XCUR0.23%99.77%Net SellingNet Selling
ENLV5.44%59.15%
View Top Biotech Stocks

Xilio Therapeutics Stock Ownership FAQ

Who owns Xilio Therapeutics?

Xilio Therapeutics (NASDAQ: XLO) is owned by 1,059.40% institutional shareholders, 929.30% Xilio Therapeutics insiders, and 0.00% retail investors. Gilead Sciences Inc is the largest individual Xilio Therapeutics shareholder, owning 9.11M shares representing 242.81% of the company. Gilead Sciences Inc's Xilio Therapeutics shares are currently valued at $67.65M.

If you're new to stock investing, here's how to buy Xilio Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.